A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study To Evaluate Efficacy And Safety And The Maintenance Of Effect Of 20-Mg Seltorexant As Adjunctive Therapy To Antidepressants In Adult And Elderly Patients With Major Depressive Disor
Posted Date: Sep 9, 2024
- Investigator: Caleb Adler
- Specialties: Depression, Psychiatry/Psychology
- Type of Study: Drug
The purpose of this study is to see if a drug called seltorexant (JNJ-42847922) added to current antidepressant treatment would help to improve depression and sleep problems (such as difficulty falling asleep, staying asleep, waking up too early or otherwise poor-quality sleep). The effects of seltorexant will be compared to the effects of placebo (pill without a medicine in it).
Criteria:
Null
Keywords:
Depression, Insomnia
For More Information:
Corey Deel
513 558-3674
deelcy@ucmail.uc.edu